Recruiting

CMP vs. Fascia Iliaca Block

Sponsor:

Loyola University

Code:

NCT04426058

Conditions

Pain, Postoperative

Hip Arthroplasty

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

CMP

Fascia Illica

Study Details

Brief summary:

Complete motorsparing protocol (CMP) has been developed to try to minimize the motor nerve block that is created when using Facia iliaca nerve block. The blocks performed in the (CMP) are the cluneal nerve block, Pericapsular nerve group block and lateral femoral cutaneous block. On the clinical trial, the investigators will randomize the participants that meet criteria to CMP or Fascia iliaca Block and compare the amount of opioid needed post op during 24 hours and their pain scores.

Conditions

Pain, Postoperative

Hip Arthroplasty

Study ID

NCT04426058

Start date

Jun 6, 2020

Status verified date

Apr, 2022

Completion date

Dec 31, 2022

Anticipated

Primary completion date

Dec 31, 2022

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patients ≥ 18 years old
  • Patients undergoing total hip arthroplasty posterior approach.
  • Patients willing to participate and sign informed consent

Exclusion Criteria:

  • Severe COPD/other contraindication to general anesthesia that spinal would be more suitable.
  • Patient with a weight of less than 41 kg
  • Dementia, not alert or Oriented to person, place, or time
  • Chronic pain patient with daily opioid use at home.
  • Patient with allergy to local anesthetics
  • Patient refusal
  • Total hip arthroplasty revision
  • Concomitant pain in different area from operative site.
  • Pregnancy
  • Patient with active infection on the injection sites for the blocks
  • Patients unable or willing to understand or comply with the study protocol

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: CMP

Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml

active comparator: Fascia iliaca

Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml

Interventions

CMP

Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml

Fascia Illica

Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml

Primary outcome measure

  • Measurement of opioid use [ Time Frame: 24 hours ]

Central Contacts and Locations

Central contacts

Carlos Martinez Parra, MD

(708) 216-6462carlos.martinezparra@lumc.edu

Michael Majewski, MD

(708) 216-6462mimajewski@lumc.edu

Locations

Loyola University Medical Center

Recruiting

Maywood, Illinois, United States, 60153

Contacts

Scott Byram, MD

713-216-5988sbyram@lumc.edu

More Information

Sponsor

Loyola University

Last update posted

Apr 20, 2022

Last verified

Apr, 2022

Keywords

  • Nerve Block
  • Fascia Iliaca Nerve Block
  • Complete Motor Sparing Protocol
  • Hip Arthroplasty
  • Pain control

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Loyola University on 2022-04-20.